AngioDynamics, Inc. revenue by segment ANGO

AngioDynamics, Inc. splits its revenue into 2 lines in its filings. The largest line in Q1 of fiscal 2027, the quarter ended Aug 31, 2026 was Med Device at $41.0 million, 51% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Aug 31, 2026
Q1 FY2027
Aug 31, 2026
Q4 FY2026
May 31, 2026
Q3 FY2026
Feb 28, 2026
Q2 FY2026
Nov 30, 2025
Q1 FY2026
Aug 31, 2025
Q4 FY2025
May 31, 2025
Q3 FY2025
Feb 28, 2025
Q2 FY2025
Nov 30, 2024
Revenue
325
81
87
78
79
76
80
72
73
Med Device
171
+2.4%
share 52.5%
41
+1.4%
share 50.7%
—
41
+1.2%
share 52.5%
44
+6.0%
share 55.1%
40
share 53.4%
—
41
share 56.5%
41
share 56.7%
Med Tech
155
+15.4%
share 47.5%
40
+13.2%
share 49.3%
—
37
+19.0%
share 47.5%
36
+13.0%
share 44.9%
35
share 46.6%
—
31
share 43.5%
32
share 43.3%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ANGO (Nasdaq)
Fiscal year ends
May 31
Incorporated in
DE
Headquarters
Latham, NY
SEC filer status
Accelerated filer
SEC CIK
1275187

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.